Literature DB >> 16480703

ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease.

Sangmee Ahn Jo1, Kyungsook Ahn, Ji-Hyun Kim, Byung-Hak Kang, Eunkyung Kim, Inho Jo, Doh Kwan Kim.   

Abstract

BACKGROUND: One of the characteristic features of Alzheimer's disease (AD) is the degeneration of the cholinergic system. The gene encoding choline acetyltransferase (ChAT), a key enzyme in cholinergic function, is a candidate gene conferring risk for AD. But the genetic association of the enzyme with AD has been controversial. We analyzed 2 ChAT single nucleotide polymorphisms (SNPs), 2384G>A (rs3810950; Ala120Thr) and 1882G>A (rs1880676; Asp7Asn) and the ApoE polymorphisms in Korean population.
METHODS: The samples from 316 AD patients and 264 age-matched healthy controls were analyzed. The differences in genotype frequencies were assessed.
RESULTS: The 2 ChAT SNPs were almost completely linked with each other (r2=0.99, |D'|=1.0). No significant difference in the ChAT genotype distribution was observed between the patients and the controls. However, in non-ApoE-epsilon4 allele carriers, multiple logistic regression analysis showed that both the GA and the GA/AA genotypes were associated with AD (OR=1.639, 95% CI, 1.050-2.559, p=0.0297 for GA; OR=1.630, 95% CI, 1.049-2.532, p=0.0297 for GA/AA), suggesting a dominant effect of A allele.
CONCLUSION: There is considerable effect of the ChAT polymorphisms on AD in Korean population and this effect is dependent on ApoE genotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480703     DOI: 10.1016/j.cca.2005.12.037

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Genetic variants in the choline acetyltransferase (ChAT) gene are modestly associated with normal cognitive function in the elderly.

Authors:  J Mengel-From; K Christensen; M Thinggaard; M McGue; L Christiansen
Journal:  Genes Brain Behav       Date:  2011-09-21       Impact factor: 3.449

2.  Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample.

Authors:  Andrew McQuillin; Nicholas Bass; Adebayo Anjorin; Jacob Lawrence; Radhika Kandaswamy; Greg Lydall; Jennifer Moran; Pamela Sklar; Shaun Purcell; Hugh Gurling
Journal:  Eur J Hum Genet       Date:  2011-01-05       Impact factor: 4.246

Review 3.  Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer's Disease: A Meta-Analysis.

Authors:  Yong Liu; Qicong Chen; Xu Liu; Mengmeng Dou; Silu Li; Jiahui Zhou; Hong Liu; Yongfu Wu; Zunnan Huang
Journal:  Biomed Res Int       Date:  2016-08-15       Impact factor: 3.411

Review 4.  Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis.

Authors:  Hai Yuan; Qing Xia; Kang Ling; Xiaotong Wang; Xiumin Wang; Xunping Du
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

5.  Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk.

Authors:  Lili Gao; Yan Zhang; Jinghua Deng; Wenbing Yu; Yunxia Yu
Journal:  Med Sci Monit       Date:  2016-06-07

6.  Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease.

Authors:  Xuting Xu; Yunliang Wang; Lingyan Wang; Qi Liao; Lan Chang; Leiting Xu; Yi Huang; Huadan Ye; Limin Xu; Cheng Chen; Xiaowei Shen; Fuqiang Zhang; Meng Ye; Qinwen Wang; Shiwei Duan
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

7.  The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer's Disease.

Authors:  Kang Uk Lee; Jung Hie Lee; Dong Young Lee; Jong Chul Youn; Jeong Lan Kim; Seok Woo Moon; Bong-Jo Kim; Seung-Ho Ryu; Moon Doo Kim; Chang-Uk Lee; Nam-Jin Lee; Sung Man Chang; Young Hoon Kim; Do Hoon Kim; Hae-Kook Lee; Jong Inn Woo; Ki Woong Kim; Jin Hyeong Jhoo
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-08-31       Impact factor: 2.582

Review 8.  Curcumin: a natural substance with potential efficacy in Alzheimer's disease.

Authors:  Pamela E Potter
Journal:  J Exp Pharmacol       Date:  2013-05-02

9.  CHAT gene polymorphism rs3810950 is associated with the risk of Alzheimer's disease in the Czech population.

Authors:  Alice Hálová; Jana Janoutová; Laura Ewerlingová; Vladimír Janout; Ondřej Bonczek; Tomáš Zeman; Tereza Gerguri; Vladimir J Balcar; Omar Šerý
Journal:  J Biomed Sci       Date:  2018-05-14       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.